Planet Briefing

First published · Last updated

Synergistic effects and molecular mechanisms of pirfenidone combined with EGFR-TKIs in non-small cell lung cancer

Journal article reporting on combined use of pirfenidone and EGFR-TKIs in non-small cell lung cancer. The supplied source data includes only the title, publisher, and publication metadata without study details.

Categories: science-and-space, public-health

Generated scores

Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.

Confidence
2/10
Geographic reach
1/10
Global importance
3/10
Impact magnitude
3/10
Positivity
5/10
Urgency
2/10

Why it matters

The article presents research findings about a drug combination relevant to non-small cell lung cancer.

Sources

Report an issue